Clinical Features Associated With Outcomes in Lung Cancer Patients Treated With Denosumab
In this large international cohort, patients treated with denosumab had lower mortality and fewer SREs than those who did not receive denosumab, adding to the growing body of evidence supporting its clinical benefit.
Authors
- Wan-Hsuan Hsu
- Bo-Wen Shiau
- Ching‐Yi Chen (ORCID: https://orcid.org/0000-0002-1978-6424)
- Yu-Feng Wei (ORCID: https://orcid.org/0009-0003-3634-3136)
- Chih-Cheng Lai
Institutions
- National Sun Yat-sen University (TW)
- Chi Mei Medical Center (TW)
- I-Shou University (TW)
Publication Details
- Journal
- Clinical Oncology
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1016/j.clon.2026.104067
- Primary Topic
- Bone health and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00